AU Patent

AU2015208932B2 — (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors

Assigned to AstraZeneca AB · Expires 2017-02-16 · 9y expired

What this patent protects

The present disclosure relates to certain (2

USPTO Abstract

The present disclosure relates to certain (2

Drugs covered by this patent

Patent Metadata

Patent number
AU2015208932B2
Jurisdiction
AU
Classification
—
Expires
2017-02-16
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.